We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





Abbott Highlights Point of Care Management Solutions

By LabMedica International staff writers
Posted on 31 Jan 2019
Abbott Diagnostics (Lake Forest, IL) highlighted its AegisPOC Point of Care Management Solutions at MedLab Middle East 2019 held in Dubai, UAE, from February 4-7, 2019. More...
MedLab Middle East is a leading laboratory and flagship exhibition and conference spanning across the Middle East, Asia and West Europe, which encompasses event for every specialism within the laboratory management and diagnostics spectrum.

At MedLab 2019, Abbott highlighted the AegisPOC Point of Care Management Solutions, which has been developed to seamlessly connect point-of-care (POC) devices in the hospital or community with the laboratory. A web-based, open platform, AegisPOC allows users to better manage and share data from their POC devices from multiple brands on one flexible, scalable middleware. AegisPOC provides the ability to integrate POC devices with LIS, HIS, EMR, quality management, user management and other systems.

With AegisPOC in place, the laboratory becomes the hub for the entire system – making it easier to share test results among locations and manage patient test results from all locations. AegisPOC reduces the workload required to manage POC devices. Users can automatically, remotely manage quality control for the whole system, along with automating user certification and re-certification training. AegisPOC brings all POC devices together seamlessly, improving data management capabilities and eliminating the need for multiple propriety middleware.


New
Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Urine Chemistry Control
Dropper Urine Chemistry Control
New
Automatic Chemiluminescence Immunoassay Analyzer
Shine i2000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The patented biosensor measures enzymatic activity associated with inflammatory disease (Photo courtesy of Hawkeye Bio)

Non-Invasive and Radiation-Free Diagnostic Identifies Early-Stage Lung Cancer Across All Subtypes

Lung cancer remains the leading cause of cancer-related deaths, with nearly 125,000 deaths and 227,000 new cases estimated in the U.S. for 2025. Despite evidence showing that early detection significantly... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.